GeoVax Begins Oncology Immunotherapy Program
GeoVax to Apply Its MVA-VLP Vaccine Technology to Cancer Immunotherapy Collaborative Research Agreement Signed With University of Pittsburgh ATLANTA, GA - (NewMediaWire) - December 08, 2015 - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company …